Target intelligence / Profile preview

Microbiome Modulator

Molecular classification
Dietary Component, Pharmaceutical, Probiotic, Prebiotic, Synbiotic, Fecal Microbiota Transplant, Bacteriophage, Nutraceutical, Immune-modulating therapy, Other
01

Overview

A microbiome modulator is a broad class of agents, interventions, or strategies designed to intentionally alter the structure and function of microbial communities, most commonly in the human gut, to achieve beneficial health outcomes. These modulators can be natural, induced, or engineered and may include dietary components, pharmaceuticals, probiotics/prebiotics/synbiotics, fecal microbiota transplantation (FMT), bacteriophages, nutraceuticals, and even immune-modulating therapies. They act via complex interactions between microbes and their human hosts at molecular levels involving both direct ecological shifts and indirect modulation through metabolite-receptor signaling pathways.

Other names
Gut Microbiome ModulatorMicrobiota ModulatorMicrobial Community Modulator
02

Mechanism of action

Varies depending on the specific modulator: - Direct alteration of microbial composition (probiotics, antibiotics). - Provision of selective substrates for beneficial microbes (prebiotics). - Transfer of entire microbial communities (FMT). - Modulation of host-microbe signaling pathways.

03

Biological functions

Modulation of microbial compositionRestoration of microbial diversityCorrection of dysbiosisEnhancement of beneficial metabolite productionSuppression of pathogenic microorganismsSupport of host metabolic functionsModulation of immune responsesOther
04

Disease associations

Gastrointestinal disordersImmune-mediated diseasesMetabolic syndromesNeurological conditionsOther
05

Safety considerations

Antibiotic resistanceRisk of infection (FMT)Potential for adverse reactions (probiotics, prebiotics)Variability in individual responsesLong-term effects unknown
06

Interacting drugs

Antibiotics (e.g., Rifaximin)

5 more in the full profile.

07

Biomarkers

Changes in microbial composition (e.g., relative abundance of specific taxa)Levels of microbial metabolites (e.g., short-chain fatty acids)Markers of inflammationMarkers of metabolic functionMental health parameters

Beyond the preview

Go deeper on Microbiome Modulator.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiome Modulator.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call